At the lower limit ofp> 0.005 for CD107a detection with antibody, 0.16 ng/mL, there was an average of 627 molecules that could be bound per Raji cell. NK-92-CD16A CD107a detected differences in antibody fucosylation. but unsuitable IU1-47 as a surrogate assay to monitor cell death after ADCC. Keywords:antibody-dependent cell-mediated cytotoxicity, ADCC, NK-92 cells, CD16A, CD107a, fucosylation, GA101 == 1. Introduction == Antibody-dependent cell-mediated cytotoxicity (ADCC) by natural killer (NK) lymphocytes is usually a form of long-lasting immunity that provides protection against many viruses (examined [1]). Antibodies that support ADCC (IgG1 and IgG3 [2,3]) are sustained throughout an individuals lifetime. IgG1 antibodies will support killing at concentrations as low as 0.1 ng/mL [4], indicating that ADCC will persist even as antibody levels decrease with time. Effective antibodies include those that are unable to neutralize viral infectivity [5]. These antibodies identify many viral epitopes in addition to those of viral receptor-binding domains (RBDs) that are essential for viral access into cells [6]. The NK cells responsible for ADCC are abundant, circulate throughout the body, Mouse monoclonal antibody to Keratin 7. The protein encoded by this gene is a member of the keratin gene family. The type IIcytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratinchains coexpressed during differentiation of simple and stratified epithelial tissues. This type IIcytokeratin is specifically expressed in the simple epithelia lining the cavities of the internalorgans and in the gland ducts and blood vessels. The genes encoding the type II cytokeratinsare clustered in a region of chromosome 12q12-q13. Alternative splicing may result in severaltranscript variants; however, not all variants have been fully described and constitute 1020% of all the blood lymphocytes. CD16A expressed by NK cells will identify the Fc region of IgG antibodies attached to viral proteins in the plasma membranes of infected cells. ADCC by NK cells kills immediately, unlike cytotoxic memory T cells that need a recall response before they can effectively kill [7,8]. In light of the potency of ADCC, quantification of ADCC-supportive antibodies is usually desirable to assess the strength of long-term anti-viral protection. Straightforward quantification of antibodies is unable to predict the ability of antibodies to support ADCC because of post-translational modifications of the Fc [9,10,11,12]. In particular, fucosylation of the antibody Fc reduces its affinity for CD16A [13,14] and thereby reduces the ability of fucosylated antibodies to support ADCC [4,15,16]. Intra-donor variations in afucosylation range between 2% and over 24% of IgG1 molecules, e.g., for antibodies to SARS-CoV-2 [17,18]. Currently, measurements of afucosylation for antigen-specific antibodies utilize affinity purification of the antibodies and mass-spectrometry; however, these techniques have limited clinical use because they are costly in terms of both money and time. This approach is also impractical due to the limited volumes of clinical serum samples. Simpler and faster assays are needed to titrate the effective antibodies in serum samples. Here, we statement IU1-47 a fast NK cell-based assay for the detection of specific antibodies that support ADCC, which is usually impartial of antibody purification and requires only small amounts of antibodies. The assay depends on NK cell externalization of lysosomal-associated membrane protein 1 (LAMP-1), also designated as CD107a [19,20,21]. CD107a lines the inner membranes IU1-47 of lysosomes and intracellular granules. In NK and CD8 cytotoxic T cells, the granules contain cytotoxic proteins (perforin and granzymes) that are released during killing (examined [22]). During cytotoxic granule release, the granule membrane fuses with and is incorporated into the cytotoxic cells extracellular plasma membrane. In the process, CD107a becomes externalized [23]. Externalization of CD107a is usually a hallmark of receptor engagement of effector killer cells with target cells for both cytotoxic T cells [24,25] and NK cells [25]. CD107a has been used as a IU1-47 surrogate marker to indicate cytotoxic activity. A previous report of CD107a externalization by NK-92-CD16A cells monitored the development of antibodies towards influenza after vaccination or natural contamination [26]. This assay with microtiter-plated antigens required hours for NK cell externalization and tittered rather than quantified the influenza-specific antibodies. Also, as.